Published Mar 13, 2023

Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker

Scott Galloway explores the intricacies of investment diversification through his NJOY experience, scrutinizes the JetBlue-Spirit merger amid antitrust challenges, and evaluates WeightWatchers' strategic shift into obesity treatment with its acquisition of an Ozempic maker, providing a comprehensive look at pivotal trends in finance, aviation, and health.
Episode Highlights
The Prof G Pod with Scott Galloway logo

Popular Clips

Episode Highlights

  • Antitrust Concerns

    The JetBlue-Spirit merger has sparked significant antitrust concerns, with the U.S. Department of Justice (DOJ) suing to block the acquisition due to fears of reduced competition. supports the DOJ's intervention, citing a history of unchecked mergers leading to monopolistic practices, such as Facebook's acquisition of Instagram and Google's purchase of YouTube 1. He argues that the airline industry is already too concentrated, and further consolidation could harm consumers. Despite JetBlue's claim that the merger would enhance competition, Scott remains skeptical, emphasizing the need for aggressive regulatory action 1.

       

    Market Dynamics

    Market dynamics in the airline industry reveal the potential negative impact of consolidation on consumer prices and competition. Scott highlights that when Spirit Airlines operates a route, ticket prices drop by 17%, but when they exit, prices increase by 30% 2. This pattern suggests that JetBlue's acquisition of Spirit could lead to higher prices, benefiting shareholders but disadvantaging consumers. The DOJ's challenge to the merger underscores the importance of protecting consumer interests in a market dominated by a few major players 1.

Related Episodes